Abstract | OBJECTIVE: To verify whether a synthetic therapeutic killer decapeptide (KP), a functional mimotope of a yeast killer toxin with wide-spectrum microbicidal activity, inclusive of AIDS-related opportunistic micro-organisms, through interaction with beta-glucan receptors, which has been found to possess sequence homology with critical segments in gp160 V1/V2 and V3 loops, may also be inhibiting HIV-1 replication. METHODS: Primary peripheral blood mononuclear cells (PBMCs) cultures established from HIV-1-infected patients were treated with KP in comparison with zidovudine and supernatants and cells were harvested for analysis of HIV RNA and proviral contents, respectively. Virus production in exogenous in-vitro PBMCs infection with lymphocytotropic and monocytotropic HIV-1 strains was also assessed in presence of KP by enzyme-linked immunosorbent assay HIV p24 gag antigen detection. The binding affinity of KP to CD4, CCR5 and CXCR4 was evaluated on CD4-CCR5 or CD4-CXCR4 transfected astroglioma cell lines. RESULTS: KP was shown to be devoid of cytotoxicity on PBMCs and to inhibit HIV-1 replication in PBMCs of a patient in the acute phase of infection. The antiretroviral activity of KP, which proved to be more potent than zidovudine at micromolar concentrations, is abolished by beta 1,3-glucan but not by beta 1,6-glucan. Down-regulation of CCR5 co-receptor, and/or physical block of the gp120-receptor interaction are possible mechanisms of KP activity. CONCLUSION: KP appears to be the first antibody-derived short peptide displaying an inhibitory activity against HIV-1 and related opportunistic micro-organisms by different mechanisms of action.
|
Authors | Claudio Casoli, Elisabetta Pilotti, Carlo Federico Perno, Emanuela Balestra, Eugenia Polverini, Antonio Cassone, Stefania Conti, Walter Magliani, Luciano Polonelli |
Journal | AIDS (London, England)
(AIDS)
Vol. 20
Issue 7
Pg. 975-80
(Apr 24 2006)
ISSN: 0269-9370 [Print] England |
PMID | 16603848
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-HIV Agents
- HIV Envelope Protein gp160
- Peptides
- RNA, Viral
- Receptors, CCR5
- Receptors, CXCR4
- Zidovudine
|
Topics |
- AIDS-Related Opportunistic Infections
(drug therapy, immunology, virology)
- Anti-HIV Agents
(immunology, therapeutic use)
- CD4-Positive T-Lymphocytes
(immunology)
- Cells, Cultured
- Down-Regulation
(immunology)
- HIV Envelope Protein gp160
(chemistry)
- HIV Infections
(drug therapy, immunology, virology)
- HIV-1
(drug effects, physiology)
- Humans
- Leukocytes, Mononuclear
(immunology)
- Molecular Mimicry
(immunology)
- Peptides
(chemistry, immunology, therapeutic use)
- RNA, Viral
(analysis)
- Receptors, CCR5
(immunology)
- Receptors, CXCR4
(immunology)
- Sequence Alignment
- Virus Replication
(drug effects, immunology)
- Zidovudine
(immunology, therapeutic use)
|